Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on paediatrics
- 30 September 2022
- Research
The study explored the impact of COVID-19 on children with serious allergies.
It concluded that children are at lower risk of developing severe COVID-19 or dying from infection. Allergic diseases are not associated with a higher COVID-19 severity and mortality, apart from severe/poorly controlled asthma. Although children faced a multitude of pandemic-related issues, allergic conditions were effectively treated remotely while reduction in air pollution and lack of contact with outdoor allergens resulted in improvement, particularly respiratory allergies.
This statement from the EAACI-section on paediatrics provides recommendations regarding allergic diseases and immunodeficiencies in children based on the lessons learnt from the COVID-19 pandemic as per current best evidence.
Read the full study on Wiley Online Library.
